Technology and products: cancer: Quest Diagnostics

Article Abstract:

Teterboro, NJ-based Quest Diagnostics Inc. is launching a new service to perform high-risk human papillomavirus (HPV) DNA testing for women with inconclusive results on their ThinPrep Pap Test for cervical cancer or its precursors.

Quest Diagnostics Inc., DGX

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Immunoassay: NMP179 may reduce uncertainty of mildly abnormal pap smears

Article Abstract:

Matritech's new test (NMP179) may reduce the uncertainty, apprehension and cost associated with millions of mildly abnormal Pap smears, according to a new report.

Matritech Inc., NMPS

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Neopath: Neopath's Autopap System succeeds in Kaiser Permanente clinical study

Article Abstract:

The Neopath AutoPap System significantly outperforms current pap tests, according to a study by Kaiser Permanente Medical Group.

Neopath Inc., NPTH

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Brief Article, Medical testing products, Cancer diagnosis
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.